U-Blot® Research Grade tepilukimigCat. No. WA3640Request quote
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade tepilukimigCat. No. WA3640
U-Blot® Research Grade TengonerminCat. No. WA3639
U-Blot® Research Grade TeneliximabCat. No. WA3638
U-Blot® Research Grade TenecteplaseCat. No. WA3637
U-Blot® Research Grade TenatumomabCat. No. WA3636
U-Blot® Research Grade TemtokibartCat. No. WA3635
U-Blot® Research Grade TelitaciceptCat. No. WA3634
U-Blot® Research Grade TelisotuzumabCat. No. WA3633
U-Blot® Research Grade TelimomabCat. No. WA3632
U-Blot® Research Grade telikibartCat. No. WA3631
U-Blot® Research Grade TelazorlimabCat. No. WA3630
U-Blot® Research Grade TegoprubartCat. No. WA3629